Rhenman & Partners Asset Management Ab
Rhenman & Partners Asset Management AB is an independent asset manager headquartered in Stockholm, Sweden, founded in 2008. The firm specializes exclusively in the healthcare sector and manages the portfolio for the Luxembourg-based Rhenman Healthcare Equity L/S fund. Their team consists of experienced financial professionals working closely with a Scientific Advisory Board of eminent medical experts. The firm serves both professional and retail investors in multiple European and Asian markets.
Investment Strategy
Rhenman & Partners Asset Management employs a highly specialized, sector-focused strategy investing only in healthcare companies, including pharmaceuticals, biotech, medical technology, and healthcare services. Their investment process integrates both scientific and financial analysis, leveraging close collaboration with a distinguished Scientific Advisory Board. This enables identification of emerging trends, breakthrough innovations, and opportunities for above-average returns by focusing strongly on a deep, research-driven understanding of healthcare markets and companies.
Top Holdings
Equity Positions (88)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
L LLY | LILLY ELI & CO | 5.70% | $45.1M | 57,870 | $567.90 | $779.53 | +$10.6M |
B BSX | BOSTON SCIENTIFIC CORP | 4.02% | $31.8M | 296,000 | $42.53 | $107.41 | +$1.5M |
V VRTX | VERTEX PHARMACEUTICALS INC | 3.46% | $27.4M | 61,455 | $321.21 | $445.20 | -$5.0M |
G GKOS | GLAUKOS CORP | 3.07% | $24.3M | 235,000 | $100.05 | $103.29 | -$2.3M |
I ISRG | INTUITIVE SURGICAL INC | 3.05% | $24.1M | 44,350 | $340.43 | $543.41 | -$1.4M |